Back
Hepion Pharmaceuticals Stock Price Chart
Sponsored
HEPA
Sponsored
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
25
HEPA
Hepion Pharmaceuticals
Last Price:
0.64
Seasonality Move:
4.62%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Hepion Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.69 | Sell |
50-day SMA: | 0.71 | Sell |
200-day SMA: | 1.56 | Sell |
8-day EMA: | 0.66 | Sell |
20-day EMA: | 0.69 | Sell |
50-day EMA: | 0.76 | Sell |
200-day EMA: | 2.05 | Sell |
Hepion Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 41.69 | Sell |
Chaikin Money Flow: | 3778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.65 - 0.75) | Sell |
Bollinger Bands (100): | (0.69 - 1.11) | Sell |
Hepion Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Hepion Pharmaceuticals Stock
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.65 while HEPA 8-day simple moving average is 0.66, which is a Sell signal.
- The stock price of HEPA is 0.65 while Hepion Pharmaceuticals 20-day SMA is 0.69, which makes it a Sell.
- Hepion Pharmaceuticals 50-day simple moving average is 0.71 while HEPA share price is 0.65, making it a Sell technically.
- HEPA stock price is 0.65 and Hepion Pharmaceuticals 200-day simple moving average is 1.56, creating a Sell signal.
HEPA Technical Analysis vs Fundamental Analysis
Sell
25
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a Sell
The current Hepion Pharmaceuticals [HEPA] share price is $0.65. The Score for HEPA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Hepion Pharmaceuticals Stock Info
Market Cap:
3.77M
Price in USD:
0.65
Share Volume:
3.78K
Hepion Pharmaceuticals 52-Week Range
52-Week High:
5.31
52-Week Low:
0.55
Sell
25
Hepion Pharmaceuticals (HEPA)
is a Sell
Hepion Pharmaceuticals Share Price Forecast
-
What is the Hepion Pharmaceuticals stock price today?
The Hepion Pharmaceuticals stock price is 0.65 USD today. -
Will HEPA stock go up or go down?
Hepion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Hepion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hepion Pharmaceuticals is overvalued.
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.65 while HEPA 8-day exponential moving average is 0.66, which is a Sell signal.
- The stock price of HEPA is 0.65 while Hepion Pharmaceuticals 20-day EMA is 0.69, which makes it a Sell.
- Hepion Pharmaceuticals 50-day exponential moving average is 0.76 while HEPA share price is 0.65, making it a Sell technically.
- HEPA stock price is 0.65 and Hepion Pharmaceuticals 200-day simple moving average is 2.05, creating a Sell signal.
Fundamental Analysis of Hepion Pharmaceuticals
Is Hepion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Hepion Pharmaceuticals
Should I short Hepion Pharmaceuticals stock?
- HEPA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Hepion Pharmaceuticals is a Sell
- Hepion Pharmaceuticals Relative Strength Index (RSI) is 41.69, which suggest Hepion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Hepion Pharmaceuticals is (0.65 - 0.75), which suggest Hepion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Hepion Pharmaceuticals is (0.69 - 1.11), which suggest Hepion Pharmaceuticals is a Sell
* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.